These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32000377)

  • 41. Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005).
    Ryu HS; Kang SB; Kim KT; Chang KH; Kim JW; Kim JH
    Int J Gynecol Cancer; 2007; 17(1):132-6. PubMed ID: 17291243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modern treatment of invasive carcinoma of the uterine cervix.
    Lilic V; Lilic G; Filipovic S; Milosevic J; Tasic M; Stojiljkovic M
    J BUON; 2009; 14(4):587-92. PubMed ID: 20148447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy.
    Lee JY; Kim YH; Kim MJ; Kim K; Chung HH; Park NH; Song YS; Kang SB
    Arch Gynecol Obstet; 2011 Aug; 284(2):477-82. PubMed ID: 20878172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
    Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
    Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
    Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
    Jewell EL; Kulasingam S; Myers ER; Alvarez Secord A; Havrilesky LJ
    Gynecol Oncol; 2007 Dec; 107(3):532-40. PubMed ID: 17900674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer.
    Prueksaritanond N; Chaisarn P; Yanaranop M
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S55-61. PubMed ID: 22619888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of cervical carcinoma IB2 stage].
    Kornovski Y; Ismail E; Kaneva M
    Akush Ginekol (Sofiia); 2012; 51(4):18-23. PubMed ID: 23234021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
    Benedetti-Panici P; Greggi S; Colombo A; Amoroso M; Smaniotto D; Giannarelli D; Amunni G; Raspagliesi F; Zola P; Mangioni C; Landoni F
    J Clin Oncol; 2002 Jan; 20(1):179-88. PubMed ID: 11773168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.
    Hequet D; Marchand E; Place V; Fourchotte V; De La Rochefordière A; Dridi S; Coutant C; Lecuru F; Bats AS; Koskas M; Bretel JJ; Bricou A; Delpech Y; Barranger E
    Eur J Surg Oncol; 2013 Dec; 39(12):1428-34. PubMed ID: 24183796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
    Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
    Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy of preoperative vaginal intracavitary irradiation for Stage Ib2 and IIa cervical cancer.
    Li F; Wu Y; Kong W; Wang J; Hao X; Niu J; Bai L
    J Cancer Res Ther; 2017; 13(5):796-800. PubMed ID: 29237906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer.
    Cheewakriangkrai C; Srisomboon J; Chitapanarux I; Suprasert P; Phongnarisorn C; Siriaree S; Charoenkwan K
    J Med Assoc Thai; 2005 Oct; 88(10):1331-7. PubMed ID: 16519375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
    Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
    Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.